Literature DB >> 32194913

Estrogen deficiency aggravates apical periodontitis by regulating NLRP3/caspase-1/IL-1β axis.

Xiaoyue Guan1, Yonghui Guan2, Chen Shi1, Ximei Zhu1, Yani He1, Zhichen Wei1, Jianmin Yang3, Tiezhou Hou1.   

Abstract

Estrogen plays critical roles in apical periodontitis and subsequent bone loss, however the mechanism is not clear yet. In this study, we aimed to study the underlying mechanism of estrogen in apical periodontitis using both clinic samples and animal model. Clinically, as estrogen physiologically declines in elder female patients (premenopausal verses postmenopausal patients), we found that the expression level of NLRP3/Caspase-1/IL-1β signaling pathway was elevated in the infected apical tissues of postmenopausal patients as compared to the premenopausal patients, suggesting that this pathway is involved in the estrogen-mediated apical periodontitis. Furthermore, by analyzing the well-established OVX (estrogen deficiency model) animal model, we confirmed that the expression level of NLRP3/Caspase-1/IL-1β signaling pathway was also elevated in the infection areas of apical periodontitis in OVX animals. Importantly, as the periodontitis progressed, the subsequent bone loss was aggravated significantly. Thus, taken all these data together, our results demonstrated that the NLRP3/Caspase-1/IL-1β signaling pathway is involved in the estrogen-mediated apical periodontitis and the consequent bone loss in both human being and animal model. This study may provide a potential target for female apical periodontitis therapy. AJTR
Copyright © 2020.

Entities:  

Keywords:  Estrogen; NLRP3/Caspase-1/IL-1β signaling pathway; apical periodontitis; bone loss; inflammation

Year:  2020        PMID: 32194913      PMCID: PMC7061852     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  46 in total

1.  What is really responsible for bone loss in spontaneous premature ovarian failure? A new enigma.

Authors:  Maria Belen Perez Lana; Vanesa Straminsky; Claudia Onetto; Juliana Martinez Amuchastegui; Georgina Blanco; Liliana Galluzzo; Sergio Provenzano; Manuel Nolting
Journal:  Gynecol Endocrinol       Date:  2010-10       Impact factor: 2.260

Review 2.  Regulation of inflammasome activation.

Authors:  Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

3.  Analysis of the expression of NLRP3 and AIM2 in periapical lesions with apical periodontitis and microbial analysis outside the apical segment of teeth.

Authors:  Shujun Ran; Bin Liu; Shensheng Gu; Zhe Sun; Jingping Liang
Journal:  Arch Oral Biol       Date:  2017-02-06       Impact factor: 2.633

4.  NLRP3 Inflammasome Involves in the Acute Exacerbation of Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Huaying Wang; Chun'er Lv; Shi Wang; Huajuan Ying; Yuesong Weng; Wanjun Yu
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

Review 5.  Mechanism of NLRP3 inflammasome activation.

Authors:  Fayyaz S Sutterwala; Stefanie Haasken; Suzanne L Cassel
Journal:  Ann N Y Acad Sci       Date:  2014-05-19       Impact factor: 5.691

6.  NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis.

Authors:  C Guo; R Fu; S Wang; Y Huang; X Li; M Zhou; J Zhao; N Yang
Journal:  Clin Exp Immunol       Date:  2018-09-16       Impact factor: 4.330

7.  Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function.

Authors:  C Minkin
Journal:  Calcif Tissue Int       Date:  1982-05       Impact factor: 4.333

8.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

Review 9.  NLRP3 Inflammasome and Inflammatory Bowel Disease.

Authors:  Yu Zhen; Hu Zhang
Journal:  Front Immunol       Date:  2019-02-28       Impact factor: 7.561

10.  NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer.

Authors:  Rajendra Karki; Si Ming Man; R K Subbarao Malireddi; Sannula Kesavardhana; Qifan Zhu; Amanda R Burton; Bhesh Raj Sharma; Xiaopeng Qi; Stephane Pelletier; Peter Vogel; Philip Rosenstiel; Thirumala-Devi Kanneganti
Journal:  Nature       Date:  2016-12-12       Impact factor: 49.962

View more
  6 in total

Review 1.  Relationship of NLRP3 inflammasome with periodontal, endodontic and related systemic diseases.

Authors:  Revan Birke Koca-Ünsal; Ahmet Özer Şehirli; Serkan Sayıner; Umut Aksoy
Journal:  Mol Biol Rep       Date:  2022-09-15       Impact factor: 2.742

2.  Glycogen synthase kinase-3β (GSK-3β) deficiency inactivates the NLRP3 inflammasome-mediated cell pyroptosis in LPS-treated periodontal ligament cells (PDLCs).

Authors:  Xiaolu Zhang; Shan He; Wanyu Lu; Lijia Lin; Hui Xiao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-04-27       Impact factor: 2.416

3.  Searching for essential genes and drug discovery in breast cancer and periodontitis via text mining and bioinformatics analysis.

Authors:  Lan Luo; Weijie Zheng; Chuang Chen; Shengrong Sun
Journal:  Anticancer Drugs       Date:  2021-11-01       Impact factor: 2.389

Review 4.  The Role of Inflammasome NLPR3 in the Development and Therapy of Periodontitis.

Authors:  Ying Zhao; Yue Quan; Ting Lei; Liumeizi Fan; Xin Ge; Sheng Hu
Journal:  Int J Med Sci       Date:  2022-09-21       Impact factor: 3.642

Review 5.  Inflammasomes in Alveolar Bone Loss.

Authors:  Yang Li; Junqi Ling; Qianzhou Jiang
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

Review 6.  Nrf2 in the Field of Dentistry with Special Attention to NLRP3.

Authors:  Lisa Schieffer; Claudia Manzl; Christoph Schatz; Johannes Haybaeck; Adriano Crismani
Journal:  Antioxidants (Basel)       Date:  2022-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.